Evaluation of NovaSure global endometrial ablation in symptomatic adenomyosis: A longitudinal study with a 36 month follow-up.

Objective: To evaluate the efficacy of NovaSure radiofrequency global endometrial ablation (GEA) in adenomyosis.

Study Design: We conducted a monocentric longitudinal cohort study at Croix-Rousse University Hospital (Lyon, France). Inclusion criteria were symptomatic adenomyosis resistant to drug therapy (dysmenorrhea and abnormal uterine bleeding (AUB)), for whom Novasure GEA was considered.